NCT00093353 2026-04-14
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
Clinical Trials
25 trialsNCT03767257 2025-10-21
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT05507736 2024-08-13
AIP2021
Fundació Sant Joan de Déu
Phase NA Completed
NCT04926545 2024-07-30
XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
Guangzhou University of Traditional Chinese Medicine
Phase NA Completed
NCT05880446 2024-05-13
PROCAR-BQ
Jules Bordet Institute
Phase NA Completed
NCT02944617 2024-02-23
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
City of Hope Medical Center
Phase NA Completed
NCT03722511 2022-11-03
Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs
University of Kentucky
Phase 2 Completed
NCT02464098 2022-02-08
Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients
St. Jude Children's Research Hospital
Completed
NCT00197873 2021-11-24
Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea
University of Helsinki
Phase NA Completed
NCT05091775 2021-10-25
The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure
Shiraz University of Medical Sciences
Phase 1/2 Completed
NCT04003181 2021-09-08
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
University of Aarhus
Phase NA Completed
NCT00748215 2020-12-02
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00258401 2020-07-27
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.
Case Comprehensive Cancer Center
Phase NA Completed
NCT01198145 2020-05-12
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT04040712 2020-03-17
Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors
Catholic University of the Sacred Heart
Phase NA Completed
NCT00258180 2019-04-16
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Johns Hopkins University
Phase 2 Completed
NCT02121626 2017-11-22
FOCCUS
Royal Marsden NHS Foundation Trust
Completed
NCT00143533 2017-04-26
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors
St. Jude Children's Research Hospital
Phase 1 Completed
NCT01523431 2017-03-30
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2/3 Completed
NCT00033605 2016-07-13
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00048971 2016-07-06
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Alliance for Clinical Trials in Oncology
Completed
NCT01164215 2015-10-09
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT01839721 2013-05-17
Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation
CHU de Quebec-Universite Laval
Phase 3 Completed
NCT00084721 2013-01-31
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT01438645 2013-01-17
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
University of Alberta
Phase NA Completed